Insider Trading April 16, 2026 04:24 PM

Palomar Holdings President Disposes of 1,937 Shares, Exercises Equivalent Options

Jon Christianson sold roughly $249,000 of stock and exercised options; company valuation metrics and Q4 2025 results highlighted

By Derek Hwang PLMR
Palomar Holdings President Disposes of 1,937 Shares, Exercises Equivalent Options
PLMR

Palomar Holdings President Jon Christianson sold 1,937 shares of the company's common stock on April 15, 2026, in multiple trades that generated about $249,142. He simultaneously exercised options to acquire an identical number of shares at $15.00 per share. The firm’s valuation metrics and recent quarterly results are noted by analysts and market tools.

Key Points

  • Palomar President Jon Christianson sold 1,937 shares on April 15, 2026, in multiple trades totaling about $249,142.
  • Christianson exercised options to acquire 1,937 shares at $15.00 per share, and now directly owns 65,919 shares including 2,410 purchased via the 2019 ESPP.
  • InvestingPro analysis flags Palomar as appearing undervalued with a P/E of 17.67 and analyst FY2026 EPS forecast of $9.84; Q4 2025 results beat expectations on both EPS and revenue.

Insider transaction details

Jon Christianson, President of Palomar Holdings, Inc. (NASDAQ:PLMR), sold 1,937 shares of the company’s common stock on April 15, 2026, receiving approximately $249,142 from the transactions. The sales were completed in multiple trades with execution prices that ranged from $128.5921 to $129.3333 per share.

Option exercise and ownership position

At the same time, Christianson exercised options to acquire 1,937 shares of Palomar Holdings common stock at an exercise price of $15.00 per share, representing a total exercise cost of $29,055. After these transactions, Christianson is reported to directly own 65,919 shares of Palomar Holdings, which includes 2,410 shares he acquired under the Palomar Holdings, Inc. 2019 Employee Stock Purchase Plan (ESPP).

Market context and valuation signals

Palomar’s share price at the time of reporting is $131.41, corresponding to a market capitalization of $3.52 billion. According to InvestingPro analysis cited in company coverage, Palomar appears undervalued on a Fair Value basis. The stock trades at a price-to-earnings ratio of 17.67. InvestingPro Tips note that this P/E level is modest relative to near-term earnings growth expectations, with analysts projecting earnings per share of $9.84 for fiscal year 2026.

The same coverage points readers to a Pro Research Report for more detailed analysis on Palomar and other U.S. equities.

Recent operating results

In separate company disclosures, Palomar reported fourth-quarter results for 2025 that exceeded analyst estimates. The company posted earnings per share of $2.24 versus a consensus forecast of $2.07. Revenue for the quarter came in at $492.6 million, ahead of the anticipated $476.63 million. Despite the upside to expectations on both earnings and revenue, the stock moved lower during the period, a decline the report attributes to broader market conditions rather than the company’s reported results.

What the filings show

The filings and the analyst commentary together document an insider sale contemporaneous with the exercise of options, the executive’s resulting shareholding, and external assessments of the company’s valuation and recent results. The reporting does not ascribe motive for the insider’s transactions beyond the recorded sales and option exercise.

Risks

  • Insider selling - The executive sale and simultaneous option exercise are factual events recorded in filings; investors may interpret such activity in different ways, creating uncertainty for equity holders and market sentiment.
  • Market volatility - Despite better-than-expected Q4 2025 results, the stock declined, indicating broader market conditions can offset company-specific performance and affect investor returns.
  • Valuation and forecast reliance - The view that Palomar appears undervalued is based on a Fair Value assessment and analyst EPS projections; such assessments and forecasts may change and introduce uncertainty for valuation-based decisions.

More from Insider Trading

Astera Labs CEO Disposes $518K in Stock Under 10b5-1 Plan Apr 16, 2026 Forager Fund Reduces Stake in Regional Management, Selling $1.44M in Shares Apr 16, 2026 Aura Biosciences Legal Chief Sells Shares to Cover Taxes as Stock Trades Near Year High Apr 16, 2026 Pinterest Director Disposes $42,000 in Stock as Analysts Weigh In Apr 16, 2026 Gilead Executive Sells $422,880 in Stock as Company Advances HIV Access and AI Collaboration Apr 16, 2026